Xconomy | Boston - Business + Technology in the Exponential Economy

Panacos Pharma Plans Layoffs
Pocket Communications Pockets $100M From Battery Ventures And Others, Nuance Makes New Bid for Zi, Xconomy Closes Second Round, & More Boston-Area Deals News
Huntington Capital and Other Venture Lenders Thriving, Despite Credit Crunch
Genzyme and Boston Scientific Get Good News From the FDA; Acusphere and Targanta Not So Much; TransMedics Pulls IPO Plug; & More Boston-Area Life Sciences News
Vertex Offering Up To $220M

Panacos to Repay $20M Loan

Panacos Pharmaceuticals (NASDAQ:PANC), a Watertown, MA-based developer of antiviral drugs for HIV, says that it has agreed to repay $17.9 million in outstanding principal, interest, and fees on a $20 million loan granted to the firm in June 2007. The repayment, which Panacos expected to execute today, follows lender Hercules Technology Growth Capital’s (NASDAQ:HTGC) claim that the company had defaulted on the terms of the loan. Panacos, which ended the third quarter with $26.9 million in cash and cash equivalents, says it is seeking partnerships and is considering options such as restructuring the company.

Comments | Permalink |